Beranda › Kanker Paru Non-Sel Kecil › Illinois › Cicero
Uji klinis Kanker Paru Non-Sel Kecil di Cicero, IL
24 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Cicero (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Menerima pesertaFase 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi jauhnya
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Edward Hines Jr VA Hospital, Hines · 4 mi jauhnya
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauhnya
- Endeavor Health, Elmhurst · 10 mi jauhnya
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Menerima pesertaFase 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi jauhnya
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Hinsdale · 10 mi jauhnya
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Menerima pesertaFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Research Site, Hinsdale · 10 mi jauhnya
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Menerima pesertaFase 2/3
- Loyola University Medical Center, Maywood · 5 mi jauhnya
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauhnya
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Hinsdale · 10 mi jauhnya
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Hinsdale · 10 mi jauhnya
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Menerima pesertaFase 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Menerima pesertaFase 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauhnya
- Edward Hines Jr VA Hospital, Hines · 4 mi jauhnya
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- dan 2 lainnya
MYLUNG Consortium Part 3: Observational Study
Menerima pesertaStudi observasional
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauhnya
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
- dan 3 lainnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
- dan 2 lainnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauhnya
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi jauhnya
- Advocate High Tech Medical Park, Palos Heights · 12 mi jauhnya
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Menerima peserta
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi jauhnya
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Cicero
- Kanker Paru17 studi
- Kanker Prostat14 studi
- Kanker (semua jenis)13 studi
- Kanker Payudara11 studi
- Leukemia Mieloid Akut11 studi
- Kanker Kolorektal10 studi
- Kanker Kandung Kemih8 studi
- Melanoma7 studi
- Penyakit Kardiovaskular7 studi
- Kanker Metastatik7 studi
- Mieloma Multipel6 studi
- Limfoma Burkitt6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.